We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Rewritten Batch Record Entries Cited in Warning Letter
Rewritten Batch Record Entries Cited in Warning Letter
September 8, 2009
Hill Dermaceuticals has received an FDA warning letter citing recordkeeping, failure to adequately investigate out-of-specification (OOS) assay results and other GMP violations.